Medical data aggregation tool developer Owkin increased its series A round to $52m after an extension backed by existing investors GV, Eight Road Ventures and F-Prime Capital.

US-based drug data collation software tool developer Owkin has extended its series A round to $52m with an extension backed by subdivisions of financial services and investment group Fidelity and internet technology group Alphabet, TechCrunch reported on Friday.

Cathay Innovation, a fund raised by private equity firm Cathay Capital, took part in the $25m extension along with state-owned investment bank Bpifrance’s Large Venture unit and France-based pension fund MACSF.

GV invested on behalf of Alphabet while Fidelity participated through two…